FDA Inspection 1268950 — Eurofins Biopharma Product Testing Switzerland AG
The FDA completed an inspection of Eurofins Biopharma Product Testing Switzerland AG on Jan 23, 2025 in Schonenwerd. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 23, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Schonenwerd (Switzerland)
Additional Details
Mutual Recognition Agreement (MRA)